Safety, Immunogenicity and Efficacy of Prime-Boost Vaccination with ChAd63 and MVA Encoding ME-TRAP against Plasmodium falciparum Infection in Adults in Senegal.

Míreanna comhchosúla

• Safety, Immunogenicity and Efficacy of Prime-Boost Vaccination with ChAd63 and MVA Encoding ME-TRAP against Plasmodium falciparum Infection in Adults in Senegal.
  de réir: Victorine A Mensah, et al.
  Foilsithe / Cruthaithe: (2016-01-01)
• Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African children and infants
  de réir: Bliss, C, et al.
  Foilsithe / Cruthaithe: (2016)
• First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children
  de réir: Tiono, AB, et al.
  Foilsithe / Cruthaithe: (2018)
• Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adults.
  de réir: Ogwang, C, et al.
  Foilsithe / Cruthaithe: (2013)
• A Phase Ia study to assess the safety and immunogenicity of new malaria vaccine candidates ChAd63 CS administered alone and with MVA CS
  de réir: De Barra, E, et al.
  Foilsithe / Cruthaithe: (2014)